What is Moberg Research?
Founded in 1998, Moberg Research, Inc., operating as Moberg ICU Solutions, is a specialized medical device manufacturer dedicated to the advancement of neurological patient monitoring. The company focuses on the intersection of clinical diagnostics and acute care, providing healthcare providers with the tools necessary to manage complex neurological conditions in intensive care settings. Its product portfolio is engineered to meet the rigorous demands of modern hospitals, ensuring that clinicians have access to real-time, actionable data for critical decision-making.
By maintaining a focus on the niche but essential field of neurocritical care, Moberg Research has established a defensible market position. The company's commitment to research and development has allowed it to navigate the complexities of international regulatory environments, successfully deploying its technology across the United States, Canada, and Europe. This operational maturity is a testament to its long-standing expertise in medical device engineering and its ability to address the specific, high-stakes needs of the acute care patient population.
How much funding has Moberg Research raised?
Moberg Research has raised a total of $3.7M across 3 funding rounds:
Private Equity
$3M
Debt
$350K
Debt
$361K
Private Equity (2017): $3M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2021): $361K supported by PPP
Key Investors in Moberg Research
PPP
Public-Private Partnership
Undisclosed Investor
A private equity participant focused on long-term value creation within the specialized healthcare and medical device manufacturing sectors.
What's next for Moberg Research?
Looking ahead, the strategic deployment of the recent $361K is expected to accelerate the company's product roadmap and market penetration efforts. With a solid foundation of capital, Moberg Research is likely to prioritize the integration of next-generation analytics into its existing monitoring platforms, potentially enhancing the predictive capabilities of its devices. Furthermore, the firm is well-positioned to explore strategic partnerships or acquisitions that could broaden its diagnostic reach within the broader critical care ecosystem.
As the healthcare industry shifts toward more data-centric and personalized patient care, Moberg Research's focus on neurological monitoring will remain a critical component of the clinical toolkit. The company's ability to sustain its growth trajectory through disciplined capital management suggests a long-term commitment to maintaining its leadership in the neurocritical care space, ultimately aiming to improve patient outcomes through technological precision.
